EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that the United States Court of Appeals for the Third Circuit has entered a Judgment affirming the decision of the U.S. District Court for the District of New Jersey dismissing, with prejudice, the Second Consolidated Amended Complaint in the Class Action litigation that was originally filed on December 20, 2002, against the Company and three of its former officers. The District Court’s decision was based on the plaintiff’s failure to set forth particularized facts, through direct or circumstantial evidence, which give rise to a strong inference that the defendants acted with intent to defraud, recklessness or a conscious disregard of the truth.
